Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Facchinetti

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Lung Cancer (Auckland, N.Z.)|October 2, 2019
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to dateFrancesco Facchinetti, Luc Friboulet
European Respiratory Review : an Official Journal of the European Respiratory Society|October 7, 2021
The efficacy of immune checkpoint inhibitors in thoracic malignanciesJordi Remon, Francesco Facchinetti, Benjamin Besse
Cancers|September 19, 2020
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized TrialsFrancesco Facchinetti, Massimo Di Maio, Marcello Tiseo
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
ESMO Open|May 12, 2020
New pathways in immune stimulation: targeting OX40Carolina Alves Costa Silva, Francesco Facchinetti, Bertrand Routy, et al.
Handbook of Experimental Pharmacology|March 24, 2017
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung CancerFrancesco Facchinetti, Claudia Proto, Roberta Minari, et al.
Current Drug Targets|January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case ReportMelissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Case Reports in Ophthalmology|May 31, 2021
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with GefitinibFabrizio Gozzi, Marcello Tiseo, Francesco Facchinetti, et al.
Immunotherapy|February 8, 2019
Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?Francesco Facchinetti, Maria Majori, Mariangela Sabato, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Lung Cancer (Auckland, N.Z.)|October 2, 2019
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to dateFrancesco Facchinetti, Luc Friboulet
European Respiratory Review : an Official Journal of the European Respiratory Society|October 7, 2021
The efficacy of immune checkpoint inhibitors in thoracic malignanciesJordi Remon, Francesco Facchinetti, Benjamin Besse
Cancers|September 19, 2020
Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized TrialsFrancesco Facchinetti, Massimo Di Maio, Marcello Tiseo
Translational Lung Cancer Research|July 23, 2021
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysisFrancesco Facchinetti, Massimo Di Maio, Fabiana Perrone, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
ESMO Open|May 12, 2020
New pathways in immune stimulation: targeting OX40Carolina Alves Costa Silva, Francesco Facchinetti, Bertrand Routy, et al.
Handbook of Experimental Pharmacology|March 24, 2017
Mechanisms of Resistance to Target Therapies in Non-small Cell Lung CancerFrancesco Facchinetti, Claudia Proto, Roberta Minari, et al.
Current Drug Targets|January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case ReportMelissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Case Reports in Ophthalmology|May 31, 2021
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with GefitinibFabrizio Gozzi, Marcello Tiseo, Francesco Facchinetti, et al.
Immunotherapy|February 8, 2019
Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?Francesco Facchinetti, Maria Majori, Mariangela Sabato, et al.
Pageof 9